May 21,2020

Incyte to Present at Upcoming Investor Conference

Incyte (Nasdaq:INCY) announced today that it will present at the Goldman Sachs 41st Annual Global Healthcare Conference (held virtually) on Tuesday, June 9, 2020 at 8:00 a.m. ET.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jun 30,2020

Kaiku Health extends its cooperation with Hirslanden Radiotherapy to digital symptom management of cancer patients undergoing oncological rehabilitation

Hirslanden Radiotherapy in Switzerland has implemented Kaiku Health as a digital patient management solution in the Oncological Rehabilitation of cancer patients in Aargau (ORA) program. The first pilot group of patients started to use Kaiku Health as a part of their rehabilitation on June 1st 2020. The rehabilitation project aims to restore patients’ physical, social and mental wellbeing during and after cancer treatments. The ORA modules last from 8 to 16 weeks. The rehabilitation program is currently available for Hirslanden Radiotherapy cancer patients regardless of cancer types.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
Jun 15,2020

Banner Health Selects Carevive to Advance Value-Based Cancer Care

Banner Health, one of the country’s largest nonprofit hospital systems, announced that they have partnered with Carevive to deliver patient care plans and provide home-based symptom management as they prepare for CMS’ Oncology Care First (OCF) model. Carevive’s oncology digital platform will integrate with Banner Health’s Cerner electronic health record (EHR) so that care teams can efficiently deliver personalized treatment care plans for the newly diagnosed patient, survivorship care plans those coming off active treatment, and to conduct home-based symptom management. Home-based symptom management will be possible using Carevive PROmpt®, a patient-reported outcomes (PRO) platform.

COLLABORATION PARTNERSHIP

#institution

#rpm

#platform

View Analyst & Ambassador Comments
Go to original news
Jun 26,2020

Roche Improves Speed and Accuracy of Non-Small Cell Lung Cancer Diagnosis with Launch of Automated Digital Pathology Algorithm

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer (NSCLC). The algorithm provides pathologists with automated assessments of scanned slide images that are objective and reproducible and have the potential to aid diagnosis and, ultimately, targeted treatment options for patients.

PRODUCT

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jun 25,2020

To PRO or not to PRO? That’s not the question

The current pandemic has put enormous pressures on cancer care, with many routine procedures completely modified. Patient Reported Outcomes (PROs) are recognised to play a key role in delivering patient-centred cancer care. OWise, the accredited and free mobile app and website developed to support breast cancer patients, has already demonstrated to improve the patient-clinician communication. It allows patients to record over 30 different side-effects and symptoms and has been successfully integrated into the EHR of NHS Lothian (Scotland).

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 08,2020

Kaiku Health expands collaboration with Roche in digital patient monitoring and management

Kaiku Health will co-develop novel digital patient monitoring and management modules in oncology, in a feasibility program conducted together with Roche. The feasibility program aims to develop three disease and treatment specific DPMM modules and test their implementation in clinical practice. The DPMM modules are developed with the aim to improve quality of life for patients, optimize healthcare resource utilisation, improve clinical workflows, and enable real-world evidence generation. The feasibility program aims to develop three disease and treatment specific DPMM modules and test their implementation in clinical practice. The DPMM modules are developed with the aim to improve quality of life for patients, optimize healthcare resource utilisation, improve clinical workflows, and enable real-world evidence generation.

COLLABORATION PARTNERSHIP

#r&d

#rpm

View Analyst & Ambassador Comments
Go to original news
Jul 16,2020

Oncology Leads Fundamental Shift to Precision Health

Health systems using CancerIQ to enable Precision Health for their cancer patient populations have seen the positive results first-hand. For instance, Adventist Health boosted cancer screening rates by 200 percent. Methodist Jennie Edmundson Hospital Breast Health Center boosted early cancer detection rates by 25% after launching their high-risk screening program and implementing the CancerIQ precision health platform.

PRODUCT

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jul 24,2020

Careology launches remote monitoring platform for cancer care

UK-based, digital cancer care platform, Careology, has launched Careology Professional - a platform for clinicians to remotely monitor their cancer patients’ health in real-time. Careology Professional allows clinicians to view and receive alerts and red flags for anomalies, vital signs, systemic anti-cancer therapy (SACT) toxicities and medication adherence. This approach facilitates early and proactive clinical intervention which can help the patient feel more supported and has the potential to be lifesaving.

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Jul 31,2020

Best Practices: Using Genetic Risk Assessment to Identify Patients Who Can't Afford to Miss Cancer Screenings

In this blog post, learn how a combination of CancerIQ’s precision health platform and telehealth helped Dr. Westgate catch cancer early.

#telehealth

#platform

View Analyst & Ambassador Comments
Go to original news
Jul 01,2020

The American Cancer Society and Flatiron Health Announce Recipients of the Real-World Data Impact Award

Three American Cancer Society researchers will receive the Real-World Data Impact Award to advance patient-centric research, the ACS and Flatiron Health announced today. The researchers, already funded by the ACS, will receive additional funding as well as access to Flatiron’s national de-identified oncology datasets curated from electronic health records for research purposes.

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY